Prognostic Impact of PCK1 Protein Kinase Activity-Dependent Nuclear SREBP1 Activation in Non-Small-Cell Lung Carcinoma

Fei Shao(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhimin Lu(Shandong Sport University), Wei Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Yibo Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongfei Jiang(Qingdao University), Daqian Xu(Zhejiang University), Xueli Bian(Nanchang University), Shuai Wang(Lanzhou Veterinary Research Institute), Jie He(First Affiliated Hospital of Jinan University), Gaoxiang Zhao(Qingdao University), Lei Zhu(Qingdao University), Juhong Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Dongming Xing(Qingdao University)
Frontiers in Oncology
March 26, 2021
Cited by 18


Related Papers

Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Lipid metabolism and cancer
|The Journal of Experimental Medicine|2020|981